[Fundamental cardiovascular effects of the Ca++ antagonistic coronary drug fendiline (author's transl)]
[Article in
German]
- PMID: 577423
Item in Clipboard
[Fundamental cardiovascular effects of the Ca++ antagonistic coronary drug fendiline (author's transl)]
[Article in
German]
Arzneimittelforschung.
1977.
No abstract available
Similar articles
-
[Fundamental cardiac and vascular effects of Ca++-antagonistic coronary drugs].Med Klin. 1975 Oct 17;70(42):1665-74. Med Klin. 1975. PMID: 1102892 Review. German. No abstract available.
-
[Pharmacological Properties of Fendiline in Cardiac and Smooth Muscle (author's transl)].Arzneimittelforschung. 1976;26(7):1321-30. Arzneimittelforschung. 1976. PMID: 1036917 German.
-
[BAY a 1040--a highly potent Ca ++ -antagonistic inhibitor of electro-mechanical coupling processes in mammalian myocardium].Arzneimittelforschung. 1972 Jan;22(1):22-33. Arzneimittelforschung. 1972. PMID: 4259147 German. No abstract available.
-
[The calcium-antagonistic fundamental effects of Verapamil on myocardial fibers and smooth muscle cells of the blood vessels].Minerva Med. 1975 May 23;66(38):1827-37. Minerva Med. 1975. PMID: 1128823 Italian.
-
[Dynamic energy participation in electrogenesis of the myocardium (author's transl)].Nihon Seirigaku Zasshi. 1975;37(11):345-58. Nihon Seirigaku Zasshi. 1975. PMID: 176348 Review. Japanese. No abstract available.
Cited by
-
Role of calcium antagonists in cardiovascular therapy.Br Heart J. 1981 Jul;46(1):8-16. doi: 10.1136/hrt.46.1.8. Br Heart J. 1981. PMID: 7023517 Free PMC article. Review.
-
Assessment of "Ca2+ -antagonist" effects of drugs in K+ -depolarized smooth muscle. Differentiation of antagonist subgroups.Naunyn Schmiedebergs Arch Pharmacol. 1982 Feb;318(3):234-40. doi: 10.1007/BF00500485. Naunyn Schmiedebergs Arch Pharmacol. 1982. PMID: 7063049